Yuvraj_pawp, Author at Pharma Advancement

Novartis has invited 60 selected students from leading international universities in 21 countries to its headquarters in Switzerland for the...

EMA and US FDA release first conclusions of parallel assessment of quality-by-design applications

by Yuvraj_pawp

22nd August 2013

The European Medicines Agency (EMA) and the United States Food and Drug Administration (US FDA) have published a joint question-and-answer...

DiaMedica completes enrollment in DM199 single ascending dose diabetes study

by Yuvraj_pawp

21st August 2013

Clinical stage biopharmaceutical company DiaMedica has completed enrollment of type 2 diabetic patients in the DM199 single ascending dose (SAD)...

FDA approves new drug to treat HIV infection

by Yuvraj_pawp

17th August 2013

The U.S. Food and Drug Administration has approved Tivicay (dolutegravir), a new drug to treat HIV-1 infection. Tivicay is an...

Novartis first company accredited with global CEO Cancer Gold Standard

by Yuvraj_pawp

12th August 2013

Novartis is the first company to earn global CEO Cancer Gold Standard accreditation by the non-profit organization CEO Roundtable on...

Novartis study of Afinitor® in advanced liver cancer does not meet primary endpoint of overall survival

by Yuvraj_pawp

8th August 2013

Novartis has announced that results of a global Phase III study showed that Afinitor® (everolimus) did not extend overall survival...

Scientists discover potential new way to treat anxiety

by Yuvraj_pawp

5th August 2013

Chemically modified inhibitors of the COX-2 enzyme relieve anxiety behaviors in mice by activating natural "endocannabinoids" without gastrointestinal side effects,...

GSK adds to its commitment to GAVI Alliance to help protect millions more children against infectious diseases

by Yuvraj_pawp

31st July 2013

GlaxoSmithKline (GSK) has increased its commitment to the GAVI Alliance to provide vaccines to developing countries, helping to protect millions...

Researchers target HER1 receptor for peptide cancer vaccine, therapeutic agents

by Yuvraj_pawp

25th July 2013

Small proteins called peptides that consist of 10 to 50 amino acids are being studied as cancer vaccines and as...

Studies suggest new key to ‘switching off’ hypertension

by Yuvraj_pawp

23rd July 2013

A team of University of California, San Diego researchers has designed new compounds that mimic those naturally used by the...

Page 103 of 106 Prev 1 … 102 103 104 … 106 Next

New Method of Drug Value: Incorporating Real-World Data

AI And The Future of Drug Discovery And Manufacturing

AI Technology Transforming Pharmaceutical Route Scouting

Advancing Biologics : New Drug Delivery Methods In Focus

Nanoparticles : Next Frontier In Pharmaceutical Innovations

Nickel Complex Innovations Streamlines Drug Development

Streamlining Toxicology Materials For IND And FIH Studies

Booming Radiopharmaceuticals Industry Attracts Investors

FDA Grants Breakthrough Status To GSKs Lung Cancer Drug

New Method of Drug Value: Incorporating Real-World Data

AI And The Future of Drug Discovery And Manufacturing

AI Technology Transforming Pharmaceutical Route Scouting

Advancing Biologics : New Drug Delivery Methods In Focus

Nanoparticles : Next Frontier In Pharmaceutical Innovations

Nickel Complex Innovations Streamlines Drug Development

Streamlining Toxicology Materials For IND And FIH Studies

Booming Radiopharmaceuticals Industry Attracts Investors

FDA Grants Breakthrough Status To GSKs Lung Cancer Drug

Yuvraj_pawp

Novartis holds annual healthcare entrepreneur competition

EMA and US FDA release first conclusions of parallel assessment of quality-by-design applications

DiaMedica completes enrollment in DM199 single ascending dose diabetes study

FDA approves new drug to treat HIV infection

Novartis first company accredited with global CEO Cancer Gold Standard

Novartis study of Afinitor® in advanced liver cancer does not meet primary endpoint of overall survival

Scientists discover potential new way to treat anxiety

GSK adds to its commitment to GAVI Alliance to help protect millions more children against infectious diseases

Researchers target HER1 receptor for peptide cancer vaccine, therapeutic agents

Studies suggest new key to ‘switching off’ hypertension

Latest News

Scalability and therapeutic potential of induced pluripotent reprogramming and neural induction using small molecules

Asahi Kasei Microdevices Advances AgeTech with Better AI-Ready Data Through New Sensor Technologies – Devices will be demonstrated at CES 2025, showing how aging in place can be safer and more accessible

Nutraceuticals 2025 takes position on international trade fair calendar, with fair slated for 5th and 6th March at new venue

UK Medicine Manufacturing Regulatory Framework For Care

Nanoemulsion Drug Delivery Enhances Tuberculosis Care

About Us

Qucik Links

Resources

System

Retrieve your password